These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37480099)

  • 61. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
    Hartmann S; Reimer T; Gerber B; Stubert J; Stengel B; Stachs A
    Eur J Surg Oncol; 2018 Sep; 44(9):1307-1311. PubMed ID: 29935839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?
    Mittendorf EA; Caudle AS; Yang W; Krishnamurthy S; Shaitelman S; Chavez-MacGregor M; Woodward WA; Bedrosian I; Kuerer HM; Hunt KK
    Ann Surg Oncol; 2014 Aug; 21(8):2468-73. PubMed ID: 24841348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.
    de Wild SR; Koppert LB; van Nijnatten TJA; Kooreman LFS; Vrancken Peeters MTFD; Smidt ML; Simons JM
    Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38531689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients.
    Acea-Nebril B; García-Novoa A; Bouzón Alejandro A; Díaz Carballada C; Conde Iglesias C
    Breast; 2023 Dec; 72():103592. PubMed ID: 37857128
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Localizing Positive Axillary Lymph Nodes in Breast Cancer Patients Post Neoadjuvant Therapy.
    Taj R; Chung SH; Goldhaber NH; Louie BH; Marganski JG; Grewal NS; Rane ZS; Ojeda-Fournier H; Armani A; Wallace A; Blair SL
    J Surg Res; 2023 Mar; 283():288-295. PubMed ID: 36423478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted axillary dissection after neoadjuvant systemic therapy in patients with node-positive breast cancer.
    Kanesalingam K; Sriram N; Heilat G; Ng EE; Meybodi F; Elder E; Brennan M; French J
    ANZ J Surg; 2020 Mar; 90(3):332-338. PubMed ID: 31845501
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Ersoy YE; Kadioglu H
    Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
    Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.
    Rubio IT
    Eur J Surg Oncol; 2016 Mar; 42(3):326-32. PubMed ID: 26774943
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy.
    Endo Y; Kotani H; Tamura N; Tanaka K; Kudo C; Sawaki M; Hattori M; Yoshimura A; Kataoka A; Nozawa K; Ozaki Y; Isogai A; Komaki R; Nakakami A; Kureyama N; Kusudo M; Hosoda W; Kawabata H; Iwata H
    Breast Cancer; 2024 Nov; 31(6):1130-1136. PubMed ID: 39312110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
    Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
    BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
    Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
    JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
    Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial.
    Chen X; Lu Z; Wang C; Lyu M; Qiao J; Sun X; Li L; Zhang C; Liu Z
    Chin Med J (Engl); 2024 Jun; 137(12):1421-1430. PubMed ID: 38557731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeted Axillary Dissection with
    Munck F; Andersen IS; Vejborg I; Gerlach MK; Lanng C; Kroman NT; Tvedskov THF
    Ann Surg Oncol; 2023 Jul; 30(7):4135-4142. PubMed ID: 37062781
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
    Nijveldt JJ; Rajan KK; Boersma K; Noorda EM; van der Starre-Gaal J; Kate MV'V; Roeloffzen EMA; Vendel BN; Beek MA; Francken AB
    Ann Surg Oncol; 2024 Jul; 31(7):4477-4486. PubMed ID: 38523225
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.
    Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S
    Br J Radiol; 2021 Nov; 94(1127):20210788. PubMed ID: 34491822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer.
    Wu X; Lin Q; Chen G; Lu J; Zeng Y; Chen X; Yan J
    PLoS One; 2015; 10(8):e0135714. PubMed ID: 26296136
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.